Company / Profit Margin
UroGen Pharma Ltd. Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-139.8%
FY2025
5-year range
-230.7% / -139.8%
FY2021-FY2025
Trend
+1.4%
vs FY2024
Sector context
#101 of 146
Health Care
What the data says
At -139.8%, UroGen Pharma Ltd.'s profit margin ranks #101 of 146 in the Health Care sector. Profit Margin has increased for 3 consecutive years, from -230.7% in FY2022 to -139.8% in FY2025.
Based on SEC 10-K filings.
-139.8% in FY2025 with a 5-year CAGR of +584004.6%.
Improved from -170.6% to -139.8% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +90.9pp
- 5-Year Change
- +584004.6pp
- 10-Year Change
- -
Sector benchmark
#101 of 146 in Health CareTop 69% of 146This company -139.8% Sector average -796.3%
▼
+82.4% above sector average
Key checks
Key Insights
- UroGen Pharma Ltd.'s profit margin has grown for 3 consecutive years.
- In FY2025, profit margin increased 1.4% year-over-year.
- Currently 656.5pp above the Health Care sector average.
- Peak profit margin was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.09 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -139.8% | +1.4% |
| FY2024 | -141.8% | +16.9% |
| FY2023 | -170.6% | +26.1% |
| FY2022 | -230.7% | +0.0% |
| FY2021 | -230.7% | +100.0% |
| FY2020 | -584144.4% | -238170.7% |
| FY2019 | -245.2% | +96.3% |
| FY2018 | -6707.2% | - |
| FY2017 | - | - |
| FY2016 | -11.1% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026